L020 Stock Chart & Stats
€0.03
<€0.01(3.57%)
At close: 4:00 PM EDT
€0.03
<€0.01(3.57%)
Day’s Range― - ―
52-Week Range€0.03 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€7.02M
Enterprise Value-€1.10
Total Cash (Recent Filing)€15.89M
Total Debt (Recent Filing)€248.56K
Price to Earnings (P/E)0.6
Beta-0.98
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.13
Shares Outstanding162,254,330
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.70
Price to Sales (P/S)30.75
P/FCF Ratio-12.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stronger Capital StructureA materially rebuilt equity base and near-elimination of debt meaningfully reduce solvency and refinancing risk. This improved capital structure gives management multi-months of financial flexibility to fund operations or strategic initiatives without immediate reliance on dilutive financing.
History Of Positive Operating Cash FlowPrior years of positive operating cash flow demonstrate the business model can generate internal funding when execution and market conditions align. That historical cash-generation capability improves the odds management can stabilize operations and restore self-funding over a multi-month horizon.
Sizable Asset BaseA substantial asset base provides tangible optionality: collateral for credit, assets available for monetization, and resources to support restructuring or partnerships. This structural buffer helps absorb further near-term losses while strategic fixes are implemented.
Bears Say
Severe Revenue CollapseA multi-year, order-of-magnitude drop in revenue signals underlying commercial or product failures and materially reduces scale economies. Sustained low top-line undermines margin recovery, limits reinvestment capacity and increases dependence on non-operating items or external financing to sustain operations.
Persistent Cash BurnTwo consecutive years of negative operating and free cash flow create structural liquidity risk: the company will likely need external funding if the trend continues. That reliance can force dilution or costly financing, constraining long-term R&D, commercialization, or recovery plans.
Earnings Quality And VolatilityProfits driven by non-operational items while core operations incur losses indicate weak earnings quality. This structural mismatch complicates forecasting, hides commercial weakness, and raises the risk that reported profitability will reverse if one-time gains or accounting items do not recur.
Britannia Life Sciences Inc News
L020 FAQ
What was Britannia Life Sciences Inc’s price range in the past 12 months?
Britannia Life Sciences Inc lowest stock price was €0.03 and its highest was €0.07 in the past 12 months.
What is Britannia Life Sciences Inc’s market cap?
Britannia Life Sciences Inc’s market cap is €7.02M.
When is Britannia Life Sciences Inc’s upcoming earnings report date?
Britannia Life Sciences Inc’s upcoming earnings report date is Sep 02, 2026 which is in 29 days.
How were Britannia Life Sciences Inc’s earnings last quarter?
Currently, no data Available
Is Britannia Life Sciences Inc overvalued?
According to Wall Street analysts Britannia Life Sciences Inc’s price is currently Overvalued.
Does Britannia Life Sciences Inc pay dividends?
Britannia Life Sciences Inc does not currently pay dividends.
What is Britannia Life Sciences Inc’s EPS estimate?
Britannia Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Britannia Life Sciences Inc have?
Britannia Life Sciences Inc has 162,254,330 shares outstanding.
What happened to Britannia Life Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Britannia Life Sciences Inc?
Currently, no hedge funds are holding shares in DE:L020
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Britannia Life Sciences Inc
Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers specialized services in rigorous product evaluation, comprehensive safety analysis, and adherence to regulatory standards. The company supports businesses within the cosmetics, nutraceutical, and consumer packaged goods (CPG) sectors, operating extensively throughout the United Kingdom and various international markets.